Document is current
Any future updates will be listed below
-
Authors
Hotta, Takamasa
Kurimoto, Noriaki
Shiratsuki, Yohei
Amano, Yoshihiro
Hamaguchi, Megumi
Tanino, Akari
Tsubata, Yukari
Isobe, Takeshi
- License Information
-
More Information
Article History
Received: 15 February 2022
Accepted: 3 August 2022
First Online: 12 August 2022
Competing interests
: NK has received personal fees from Olympus Medical Systems Corporation outside the work performed. YT reports personal fees from AstraZeneca, Daiichi Sankyo Co., Ltd., Pfizer Health Research Foundation, and Chugai Pharmaceutical Co., Ltd., outside the work performed. TI has received personal fees from Boehringer-Ingelheim, AstraZeneca, Daiichi Sankyo Co. Ltd, Pearl Therapeutics Inc., Janssen Pharmaceutical K.K., and Pfizer outside the work performed. TH, YS, YA, MH, and AT have no conflicts of interest to declare. We built a CNN-CAD system in partnership with Olympus Medical Systems Corporation. However, there is no economic benefit to Olympus Medical Systems Corporation in this study. This work was supported by JSPS KAKENHI Grant Number JP22K18185.
